Biofrontera shares are trading higher on continued strength after Roth Capital on Wednesday initiated coverage on the stock with a Buy rating and a $20 price target.

by | Nov 26, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.